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Introduction
Tobacco use remains a major public health concern. 
Cigarette smoking is the single most preventable cause 
of death worldwide and has been linked to countless ill-
nesses, chief among them cancer, cardiovascular and res-
piratory diseases [1–6]. As many as 9% of all deaths are 
attributable to tobacco consumption, making smoking 
cessation the most cost-effective strategy for reducing 
morbidity and mortality [7–9]. According to the World 
Health Organization (WHO), global tobacco use kills 
nearly 6 million people annually, more than the human 
immunodeficiency virus (HIV), tuberculosis and malaria 
combined. Unfortunately, despite recent favorable trends 
in developed nations, more than 8 million people are 
expected to die every year by 2030 [10].
Tobacco smoking has spread globally, and is currently 
increasing in many low- and middle-income countries. It 
is slowly but steadily decreasing in several high-income 
countries [11]. Paradoxically, death rates due to smok-
ing-related illness are lower in low than in middle and 
high-income countries because of the delayed effects of 
cigarette smoking on health outcomes. Mortality in low 
and middle-income countries, especially for women, will 
therefore continue to rise in the foreseeable future, even 
if efforts to reduce smoking are successful [11].
The reduction of tobacco smoking over the past half 
century in most industrialized nations has not been 
evenly distributed among all smokers. Specifically, young 
adults, disadvantaged individuals, and women have expe-
rienced proportionally smaller declines [12, 13]. Many fac-
tors influence smoking trends, including individual-level 
variables such as socioeconomic status and education, 
as well as system-level factors such as regional economic 
development and tobacco control policies [14, 15]. 
Sociodemographic vulnerabilities may provide important 
clues for improving policy initiatives for tobacco control 
and regulation [16].
Smoking Prevalence Around the World
Worldwide, approximately 23% of adults, including 
more than 1 billion males and 250 million females, 
smoke tobacco products. This gender gap is narrowing 
as the number of female smokers has been increasing. 
Unfortunately, smoking prevalence tends to be highest 
among those with the lowest levels of education and 
income. Nearly 80% of the world’s smokers live in low 
and middle-income countries [17, 18]. Current projec-
tions indicate that globally the number of smokers will 
increase to 1.6 billion over the next 25 years. As a con-
sequence, the number of tobacco-related deaths will 
surpass the combined mortality from AIDS, tuberculosis, 
automobile accidents, maternal deaths, homicide and 
suicide [19].
Consumption of tobacco products is increasing world-
wide but unevenly; although it is decreasing in some high 
and upper middle-income countries, it is markedly increas-
ing in developing regions [20]. Such a pattern reflects the 
commercial strategy of tobacco companies; as smoking 
becomes less acceptable and profitable in the developed 
world, countries with fewer public health warnings and 
restrictions on the commercialization of tobacco products 
become target customers. 
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Tobacco smoking is recognized as a major preventable cause of disease worldwide and is linked to 6 
million deaths annually, 30% of which are due to cancer. The negative health consequences of smoking 
currently represent one of the greatest global public health challenges. Additionally, secondhand smoke, 
which was declared carcinogenic by the International Agency for Research on Cancer in 2004, is a major 
source of morbidity and premature death in nonsmokers, particularly children. Negative health effects 
associated with exposure to secondhand smoke have been well documented and include lung cancer, 
cardiovascular disease, asthma, and other respiratory diseases. International and national policies to 
implement cost-effective strategies to curtail smoking will have a significant impact on population health 
and will protect nonsmokers. Effective interventions, such as  smoking bans, tobacco price increases, easy 
access to tobacco cessation treatments, and anti-tobacco media campaigns, should continue. Reducing 
tobacco use would be a major step towards the goal of decreasing health disparities by 2030, as 80% of 
the projected tobacco-related deaths will occur in low and middle-income countries.
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Global tobacco Burden
A 2008 WHO initiative conducted an analysis of the preva-
lence of tobacco use in Africa, the Americas, South-East 
Asia, Europe, the Eastern Mediterranean, and the West-
ern Pacific [21]. The overall prevalence of smoking varied 
widely among the six WHO regions, ranking highest in 
Europe (29%) and lowest in Africa (8%). In general, men 
smoked more than women, with the largest disparities for 
daily cigarette smoking occuring in the Western Pacific 
Region, where men smoked 15 times more frequently than 
women, followed by Souteast Asia where men smoked 10 
times more often than women (Figures 1 and 2). Among 
men, the highest prevalence of smoking was in lower to 
middle-income countries. Among women, relatively high 
rates of smoking (15%) were reported in upper-middle 
and high-income countries. Smoking rates were about five 
times lower in low- and lower-middle-income countries 
and in general, smoking prevalence declined as country 
per capita income rose. 
Developed Countries
Recent data from the National Health Interview Survey 
showed that the prevalence of smoking among United 
States (US) adults aged ≥18 years has declined from 20.9% 
in 2005 to 16.8% in 2014 [22]. Smoking continues to be 
more prevalent in males, adults aged 25–44 years, mul-
tiracial individuals, and American Indian/Alaska natives. 
Smoking is also more common in individuals who 
have lower educational attainment levels, those living 
below the federal poverty level, those insured by Med-
icaid, the uninsured and patients with disabilities [22]. 
 Unfortunately, data from a 2014 study found a very high 
Figure 1: Global Smoking Prevalence in Males.
Figure 2: Global Smoking Prevalence in Females.
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prevalence of sporadic tobacco use (57.3% to 67.4%) in 
young adults, a population that should be the target of 
anti-tobacco efforts [23]. That notwithstanding, the U.S. 
has experienced a  substantial reduction in the prevalence 
of cigarette smoking since the landmark 1964 Surgeon 
General’s Report [1], especially among white males. Much 
needs to be done as very little has changed among those 
with substance abuse or other psychiatric disorders, and 
smoking has even increased within some demographics 
such as economically disadvantaged women [24].
Tobacco control in Great Britain has also improved in 
recent years. The prevalence of cigarette smoking was very 
high in the 1970s, but declined rapidly (from 45% to 35%) 
in the early 1980s. The rate of decline then slowed, with 
smoking prevalence falling by only about one percentage 
point every two years until 1994.  After 1994, the preva-
lence of smoking  stabilized at approximately 27% before 
resuming a slow decline in the first decade of the twenty-
first century [25]. Recent data from the Opinions and 
Lifestyle Survey showed that overall smoking prevalence 
has continued to decrease in Great Britain. By 2012, 20% 
of adults (aged 16 years and over) continued smoking, 
a prevalence similar to previous years, but significantly 
lower than the 26% reported in 2002 [26]. The survey also 
displayed a relationship between marriage and cigarette 
smoking in Britain. Only 14% of the married population 
were active tobacco users, as smoking was far more com-
mon among single, unmarried individuals. Men reported 
a higher prevalence of smoking than women in all socio-
economic strata with some exceptions (large employers 
and high managerial positions) [21].
Tobacco use is heterogeneous across Europe. Smoking 
is more common in Turkey, Latvia and Greece, particu-
larly among men. In Western Europe, Spain has a high 
rate of male smokers. The former Yugoslav Republic of 
Macedonia, Greece, Hungary, Poland, the Netherlands and 
France have the highest rates of smoking among women, 
while Sweden is the only member of the European Union 
where more women smoke than men [27]. Policy initia-
tives in Europe addressing tobacco use have been histori-
cally limited. Recently however, several countries, most 
notably Poland, Hungary and the Baltic states, have 
enacted tobacco legislation stricter than other European 
Union countries [28].
Low and Middle-income Countries
The Global Adult Tobacco Survey was designed to collect 
representative data on tobacco use in low-income and 
middle-income countries [29, 30]. The study included 
national surveys conducted between 2008 and 2010 in 
14 countries in Asia, America, and Europe [12]. Forty-
eight percent of men and 11% of women smoked amid 
a population of 3 billion individuals. Tobacco consump-
tion was quite varied, ranging from 21.6% of men in Bra-
zil to 60.2% in Russia. Rates of cigarette smoking among 
women were also quite varied with only 0.5% of women 
smoking in Egypt as compared to 24.4% in Poland. Women 
aged 55–64 years began smoking at an older age than did 
equivalently aged men in most countries. Younger men 
and women started smoking at similar ages. Smoking ces-
sation rates were very low overall (<20%), particularly in 
China, India, Russia, Egypt, and Bangladesh. This large col-
laborative study reinforced the view that efforts to prevent 
smoking from becoming a habit and promote cessation 
of tobacco use are needed to reduce smoking related mor-
bidity and mortality worldwide [12].
Emerging Economies
China represents a daunting public health challenge 
given that over 300 million of its citizens smoke while an 
estimated 740 million, including 180 million children, are 
exposed to secondhand smoke [31]. Approximately one 
third of global tobacco leaf production is Chinese and 
30% of all cigarettes are consumed in China. Smokers in 
China are mostly male, while only 2.4% of women smoke 
regularly compared with 63% of middle aged men 45–64 
years of age [32]. However, as many as 82% of women in 
China are exposed to secondhand smoke [33]. The preva-
lence of smoking is highest in rural areas and among the 
poorly educated. Given that mass cigarette consumption 
is relatively new to China, the impact of the current epi-
demic cannot be overstated – it is poised to surpass that 
seen in western nations with an estimated one third of 
Chinese men likely to be killed by tobacco [34].
The Negative Health Impact of Tobacco
Cigarettes are a complex mixture of highly addictive prod-
ucts: nicotine, polyaromatic hydrocarbons, Phenols and 
nitrosamines which are submicron-sized solid particles; 
other components, such as carbon monoxide, hydrogen 
cyanide and nitrogen oxides are gases. When a cigarette 
is smoked, there are approximately 600 ingredients that 
when burned, create more than 7,000 chemicals, includ-
ing at least 70 known carcinogens [35].
Overall, mortality is three to five times greater in smok-
ers than in nonsmokers for both men and women. As a 
consequence, it has been recently estimated that smokers 
can lose more than 10 years of life expectancy [36, 37]. 
Presently, the three major non-infectious causes of mor-
bidity and mortality are cardiovascular diseases, chronic 
obstructive pulmonary disease (COPD) and lung cancer, all 
preventable causes of death [38, 39, 40].
Lung cancer is a well-recognized negative consequence 
of the tobacco epidemic. Approximately 80–90% of lung 
cancer cases are tobacco-related. The risk of lung cancer is 
greater among those who start smoking at a younger age 
or who smoke “high-yield” cigarettes but is also strongly 
correlated with the cumulative lifetime smoking exposure 
[41–47]. Although lung cancer was previously consid-
ered a disease that most often affected men,  since the 
1950s lung cancer deaths among women have increased 
more than 600% [48]. As a consequence, lung cancer sur-
passed breast cancer as the leading cause of cancer deaths 
in women in the late 1980s [49, 50]. Unfortunately, the 
carcinogenic effect of tobacco is not limited to the lungs. 
Smoking generates circulating carcinogens leading to 
increased risk for several other malignancies. Tobacco 
has been linked to 13 different types of cancer including 
breast, liver, pancreas and colorectal tumors, among oth-
ers [36, 41–47, 51–52].
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Chronic Obstructive Pulmonary Disease (COPD)  is a 
major public health problem and will remain a challenge 
for clinicians in the 21st century due to its high morbidity 
and mortality rates [53]. The main risk factor for COPD is 
exposure to tobacco smoke, either active or secondhand 
smoke. Other risk factors include exposure to indoor and 
outdoor air pollution and occupational dusts and chemi-
cals [54]. Current projections estimate that by 2020, COPD 
will be the third leading cause of death worldwide behind 
heart disease and cancer, and the fifth leading cause of 
years lost through early mortality or disability [55, 56]. 
Cigarette smoking also significantly contributes to car-
diovascular morbidity and mortality. Epidemiologic stud-
ies strongly support that cigarette smoking, in both men 
and women, increases the incidence of myocardial infarc-
tion and fatal coronary artery disease [57–59]. Smoking 
accounts for 33% of all deaths from cardiovascular disease 
and 20% of deaths from ischemic heart disease worldwide 
[60]. Smoking appears to have causal relationships and 
possible synergistic interactions with other major risk fac-
tors for coronary heart disease, including hyperlipidemia, 
hypertension, and diabetes mellitus [61]. Importantly, 
nonsmokers exposed to secondhand tobacco smoke at 
home or work also have a 25–30% higher risk for heart 
disease [62–64].
Smoking and exposure to secondhand smoke are associ-
ated with primary tuberculosis (TB) infection, active dis-
ease, risk of recurrence, and TB mortality, with more than 
20% of global TB incidence being attributed to tobacco 
[65]. Smokers are also at increased risk for erectile dysfunc-
tion, cataracts, periodontitis, gastro-esophageal reflux, 
and hip fractures [41]. Moreover, new studies implicate 
tobacco as a cause of adult onset diabetes, age-related 
macular degeneration, compromised immune system and 
an increased risk for respiratory infections [41]. Women 
who smoke during pregnancy are more likely to have low 
birth weight and premature babies and increased risk for 
miscarriage [41]. There is now evidence linking smoking 
with ectopic pregnancy and orofacial cleft in newborns 
[36].
Anti-smoking Legislation and Anti-tobacco 
Campaigns
Smoking is a global concern which demands international 
cooperation, including future implementation of meas-
ures that will effectively control, and ultimately end the 
current epidemic. Decades have passed since tobacco con-
sumption was first linked to illness, particularly cancer. 
Since then, landmark anti-smoking campaigns emerged 
and gave rise to warnings about tobacco’s harmful effects 
on cigarette packs [66]. The WHO’s Framework Conven-
tion of Tobacco Control (FCTC), was the first international 
health treaty to arise from these efforts (Table 1). It was 
endorsed by 180 countries across the globe, accounting 
for 90% of the world’s population (Table 1). The treaty 
aims to provide the necessary tools for promoting effec-
tive legislative changes for controlling tobacco consump-
tion. Demand and supply were equally addressed by the 
treaty including measures related to tobacco product pric-
ing and taxation, education, and awareness. Much empha-
sis was placed on publicity and sponsorship of tobacco, 
reducing tobacco dependence as well as protecting pas-
sive smokers in public and work settings from the perils of 
secondhand  smoking.
Tax increases constitute one of the most effective means 
of controlling smoking by decreasing demand for ciga-
rettes. Arguably, controlling tobacco prices through taxa-
tion reduces the number of premature deaths linked to 
tobacco consumption and mitigates the costs by increas-
ing revenue. The income from tax can be used to spon-
sor anti-smoking initiatives and shoulder the health costs. 
Unfortunately, only 33 countries (10% of the world’s pop-
ulation), have levied taxes amounting to more than 75% 
of the product’s value. Similarly, only 29 countries have 
banned any form of tobacco advertising, while one third 
of treaty members either completely lack or barely offer 
minimum restrictions. Illicit commerce is also a growing 
problem, as approximately one out of ten cigarettes and 
other tobacco products eschew regulation and taxation 
[67]. The interdiction of such commerce will help mini-
mize the consumption of tobacco by limiting the exist-
ence of more affordable alternatives to legally purchased 
cigarettes, resulting in an increase of tobacco cost which 
historically limits their use. 
Implementation of anti-smoking legislation has led 
to large reductions in exposure to secondhand smoke. 
In Scotland, the effect has been particularly impres-
sive for nonsmokers living in nonsmoking households 
with mean cotinine concentrations falling by 49% [68]. 
Unfortunately, non-smokers living in smoking households 
had a negligible reduction. Smoke-free housing policies 
may be an effective strategy for reducing secondhand 
exposure in these individuals [69]. A recent meta-analysis 
confirmed that anti-smoking legislation implemented 
between 1991 and 2010 has led to a 12% reduction in hos-
pitalizations for acute coronary events worldwide [70]. A 
different meta-analysis published in 2012 also confirmed 
that anti-smoking legislation in 33 countries reduced the 
risk of smoking related illnesses, including cardiac, cer-
ebrovascular and respiratory diseases. In both studies, 
more comprehensive laws were associated with greater 
risk reductions and long-term benefits [71].
The need for comprehensive legislation cannot be over-
stated. In Spain, an initial attempt to protect workers from 
secondhand smoke that allowed workplaces to designate 
smoking areas was only partially effective. For nonsmok-
ing employees of bars and restaurants where smoking 
was allowed, exposure to secondhand smoke remained 
similar to pre-legislation levels. Conversely, cotinine lev-
els decreased by 56% in workplaces where smoking was 
totally prohibited [72]. Internal tobacco industry docu-
ments made public through US litigation settlements 
show that tobacco companies have promoted separate 
seating for smokers and ineffective ventilation technolo-
gies [73]. Fortunately, continued efforts have led to more 
comprehensive legislation. For example, the original 
Spanish anti-tobacco law approved in 2005 was amended 
in 2010 and overall reductions in exposure to second-
hand smoke reached 22% between 2005 and 2007, fol-
lowed by an additional 17% between 2007 and 2011 as 
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a result of the new legislation [74]. Data shows that spe-
cial emphasis must be placed on young individuals and 
frequently overlooked tobacco exposure settings [75]. 
In Italy, for example, despite comprehensive legislation, 
secondhand smoke exposure remained a comparatively 
high 54% in those aged 15–24 years, primarily due to 
exposure inside motor vehicles [76]. A U.S. study showed 
that self-reporting is an unreliable source of secondhand 
exposure [77]. In this study, 31%  of subjects with meas-
urable cotinine and 53% of subjects with measurable 
nicotine levels did not report exposure, suggesting that 
efforts by the smokers’ lobby to categorize current legisla-
tion as exaggerated or overreaching may be misguided or 
unfounded. 
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It is legitimate, however, to consider the limits of 
 comprehensive legislation enacted to protect those 
exposed to cigarette smoke. A symposium convened by 
the Tobacco Control Legal Consortium at William Mitchell 
College of Law in 2007 is illustrative of the hurdles we 
face in advancing anti-smoking legislation in the public 
arena [78]. Participants expressed concerns about the 
implementation of zero-tolerance legislation for fear that 
it might undermine the scientific credibility of evidence-
based tobacco control policies. The authority of employ-
ers to regulate off-site smoking of their employees was 
also questioned. On the contrary, evidence was cited sup-
porting smoking bans in vehicles, especially for the wel-
fare of small children. However, anti-tobacco legislation 
can have unanticipated negative consequences. Variable 
enforcement of a ban on smoking in parks and beaches 
in Vancouver, Canada, for example, led to higher smoking 
rates in poorer neighborhoods, generating health inequi-
ties [79].
Children, arguably the most vulnerable age group and 
the focus of many efforts to curb cigarette smoking, con-
tinue to be exposed to tobacco smoke despite current 
legislation and voluntary bans on smoking. A systematic 
review of the literature showed that children of smoking 
parents are up to 13 times more likely to be exposed to 
secondhand smoke than children of non-smokers [80]. 
Studies such as these suggest that established measures 
may be reaching a point of diminishing returns, subse-
quently raising interest in alternative ‘endgame strategies,’ 
such as limiting nicotine levels, raising the pH of inhaled 
smoke, driving prices upward, or even setting a cutoff ban-
ning smoking for young adults altogether [81]. While such 
measures are often advocated, experience with alcohol 
prohibition has shown that illicit commerce will limit the 
impact of such strategies.
Conclusions
While the devastating impact smoking has on global 
health is well-accepted, continued efforts to curb its prev-
alence face ongoing challenges. Recent legislation, espe-
cially in developed nations, has demonstrated the benefit 
of tobacco bans implemented for the protection of sec-
ondhand smokers in public spaces, and ongoing efforts 
are investigating the limits of the law in curbing tobacco 
use in private spaces or shared outdoor venues. Tobacco 
cession efforts must grow as the tobacco epidemic con-
tinues unabated in some regions of the world and as we 
brace for the imminent public health impact of  smoking 
in low and middle-income countries which have only 
recently engaged in mass tobacco consumption.
Competing Interests
The authors have no competing interests to declare.
References
 1. U.S. Department of Health Education and 
 Welfare. Smoking and Health – Advisory Commit-
tee to the Surgeon General; 1964.
 2. U.S. Department of Health and Human Ser-
vices. The Health Consequences of Involuntary 
Exposure to Tobacco Smoke – A Report of the 
Surgeon  General. In: The Health Consequences of 
 Involuntary Exposure to Tobacco Smoke – A Report of 
the Surgeon General; 2006. 
 3. U.S. Department of Health and Human  Services. 
The Health Consequences of Smoking: What it 
means to you – A Report of the Surgeon General. 
The Health Consequences of Smoking; 2004. 
 4. Briggs V. Smoking and health in the Koori commu-
nity. Aboriginal and Islander Health Worker J. 1996; 
20: 17–8.
 5. National Cancer Institute. Health Effects of Expo-
sure to Environmental Tobacco Smoke: The Report 
of the California Environmental Protection Agency; 
1999. 
 6. Winstanley M, Woodward S and Walker N. 
Tobacco in Australia: Facts and Issues Victorian 
Smoking and Health Program; 1995. 
 7. U.S. Department of Health and Human Services. 
The Health Consequences of Smoking: A Report of 
the Surgeon General; 2004. 
 8. Eriksen DM, Mackay DJ and Ross DH. The Tobacco 
Atlas. 4th edition; 2012. 
 9. World Health Organization (WHO). Global 
Health Risks: Mortality and Burden of Disease Attrib-
utable to Selected Major Risks. http://www.who.
int/healthinfo/global_burden_disease/GlobalHeal-
thRisks_report_full.pdf. Accessed June 25, 2012.
 10. WHO. WHO report on the global tobacco epidemic; 
2011.
 11. WHO. WHO report on the global tobacco epidemic; 
2008.
 12. Graham H, Inskip HM, Francis B and Harman 
J. Pathways of disadvantage and smoking careers: 
Evidence and policy implications. J Epidemiol 
 Community Health. 2006; 60(Suppl 2): ii7–ii12. DOI: 
https://doi.org/10.1136/jech.2005.045583
 13. Giovino GA, Mirza SA, Samet JM, et al. Tobacco 
use in 3 billion individuals from 16 countries: an 
analysis of nationally representative cross-sectional 
household surveys. Lancet. 2012; 380: 668–79. DOI: 
https://doi.org/10.1016/S0140-6736(12)61085-X
 14. Gilmore ABC, McKee M, Telishevska M and Rose 
R. Epidemiology of Smoking in Ukraine, 2000. 
Prev Med. 2001; 33(5): 453–61. DOI: https://doi.
org/10.1006/pmed.2001.0915
 15. Pomerleau J, Gilmore A, McKee M, Rose R and 
Haerpfer CW. Determinants of smoking in eight 
countries of the former Soviet Union: results from 
the Living Conditions, Lifestyles and Health Study. 
Addiction. 2004; 99(12): 1577–85. DOI: https://doi.
org/10.1111/j.1360-0443.2004.00885.x
 16. Higgins S, Kurti A, Redner R, et al. A literature 
review on prevalence of gender differences and 
intersections with other vulnerabilities to tobacco 
use in the United States, 2004–2014. Prev Med. 
2015; 80: 89–100. DOI: https://doi.org/10.1016/j.
ypmed.2015.06.009
 17. Centers for Disease Control and Prevention. Mor-
tality trends for selected smoking-related diseases 
Perez-Warnisher et al: Tobacco Use Worldwide Art. 9, page 7 of 9 
and breast cancer – United States, 1950–1990. Mor-
bidity and Mortality Weekly Report. 1993; 42(44): 
857, 863–6.
 18. U.S. Department of Health and Human 
 Services. The Health Consequences of Smoking: A 
Report of the Surgeon General; 2004.
 19. U.S. Department of Health and Human 
­Services.  The Health Consequences of Smok-
ing—50 Years of Progress: A Report of the Surgeon 
General, 2014. Center for Disease Control and Pre-
vention MMW Rep. 2015; 64(44); 1233–1240.
 20. Jha P, Chaloupka F, Moore J, et al. Disease Con-
trol Priorities in Developing Countries. In: Tobacco 
Addiction. 2nd edition.
 21. WHO. Global status report on noncommunicable 
diseases – Description of the global burden of NCDs, 
their risk factors and determinants; 2010. http://
www.who.int/nmh/publications/ncd_report2010/
en/.
 22. Jamal A, Homa DM, O’Connor E, et al. Current 
cigarette smoking among adults – United States, 
2005–2014. MMWR Morb Mortal Wkly Rep. 2015; 
64(44): 1233–40. DOI: https://doi.org/10.15585/
mmwr.mm6444a2
 23. Richardson A, Williams V, Rath J, Villanti AC 
and Vallone D. The next generation of users: Prev-
alence and longitudinal patterns of tobacco use 
among US young adults. Am J Public Health. 2014; 
104(8): 1429–36. DOI: https://doi.org/10.2105/
AJPH.2013.301802
 24. Chilcoat HD. An overview of the emer-
gence of disparities in smoking preva-
lence, cessation, and adverse consequences 
among women. Drug Alcohol Depend. 2009; 
104(Suppl. 1): S17–S23. DOI: https://doi.org/ 
10.1016/j.drugalcdep.2009.06.002
 25. Robinson S and Bugler C. Smoking and drinking 
among adults, 2008. General Lifestyle Survey 2008. 
Newport: Office for National Statistics; 2010.
 26. Health and Social Care Information Centre. Sta-
tistics on Smoking; 2014. http://www.hscic.gov.uk/
catalogue/PUB14988/smok-eng-2014-rep.pdf.
 27. Mladovsky P, Allin S, Masseria C, 
 Hernández-Quevedo C, McDaid D and Mossialos 
E. Health in the European Union. Trend and analy-
sis. WHO; 2009.
 28. Fagerstrom K, Boyle P, Kunze M and Zatonski 
W. The anti-smoking climate in EU countries and 
Poland. Lung Cancer. 2001; 32: 1–5. DOI: https://
doi.org/10.1016/S0169-5002(00)00203-8
 29. Global Adult Tobacco Survey Collaborative 
Group. Global Adult Tobacco Survey (GATS): quality 
assurance: Guidelines and documentation, version 
2.0. http://apps.nccd.cdc.gov/gtssdata/Ancillary/
Documentation.aspx?SUID=4&DOCT=.
 30. United Kingdom Economic and Social 
Research Council. General Lifestyle Survey. Tech-
nical appendices; 2009. http://www.esds.ac.uk/
doc/6737%5Cmrdoc%5Cpdf%5C6737appendi
ces.pdf.
 31. Zhang J, Ou JX and Bai CX. Tobacco smok-
ing in China: Prevalence, disease burden, chal-
lenges and future strategies. Respirology 
2011; 16: 1165–1172. DOI: https://doi.
org/10.1111/j.1440-1843.2011.02062.x
 32. Gu D, Kelly TN, Wu X, et al. Mortality attribut-
able to smoking in China. N Engl J Med. 2009; 
360: 150–159. DOI: https://doi.org/10.1056/
NEJMsa0802902
 33. Han JX, Ma L, Zhang HW, et al. A cross sectional 
study of passive smoking of non-smoking women 
and analysis of influence factors on women pas-
sive smoking. Wei Sheng Yan Jiu. 2006; 35: 
609–11.
 34. Dobson R. One third of Chinese men will be killed 
by tobacco if high smoking rates persist. BMJ. 2009; 
338: b302. DOI: https://doi.org/10.1136/bmj.
b302
 35. Talhout R, Schulz T, Florek E, Benthem J, Wester 
P and Opperhuizen A. Hazardous compounds in 
tobacco smoke. Int J Environ Res Public Health. 2011; 
8(2): 613–628. DOI: https://doi.org/10.3390/
ijerph8020613
 36. Patel MS and Steinberg MB. Smoking cessa-
tion. Annals of Internal Medicine. 2016; 164(5): 
ITC33–ITC48. DOI: https://doi.org/10.7326/
AITC201603010
 37. Jha P, Ramasundarahettige C, Landsman V, et 
al. 21st-century hazards of smoking and benefits 
of cessation in the United States. N Engl J Med. 
2013; 368: 341–50. DOI: https://doi.org/10.1056/
NEJMsa1211128
 38. U.S. Department of Health and Human Ser-
vices. The Health Consequences of Smoking: A 
Report of the Surgeon General; 2004.
 39. U.S. Department of Health and Human 
 Services.  The Health Consequences of Smok-
ing—50 Years of Progress: A Report of the Surgeon 
General; 2014. 
 40. Lando H, Hipple B, Muramoto M, et al. Tobacco 
is a global pediatric concern. Bulletin of the World 
Health Organization. 2010; 88: 2–2. DOI: https://
doi.org/10.2471/BLT.09.069583
 41. U.S. Department of Health and Human 
­Services.  The Health Consequences of Smok-
ing—50 Years of Progress: A Report of the Surgeon 
General; 2014.
 42. Ahmed J, Homa D, O’Connor E, Babb S, et al. 
Current Cigarette Smoking Among Adults—United 
States, 2005–2014. Center for Disease Control and 
Prevention MMWR. 2015; 64(44): 1233–1240.
 43. Lando H, Hipple B, Muramoto M, et al. Tobacco 
is a global pediatric concern. Bulletin of the World 
Health Organization. 2010; 88: 2–2. DOI: https://
doi.org/10.2471/BLT.09.069583
 44. Doll R, Peto R, Wheatley K, Gray R and 
 Sutherland I. Mortality in relation to smoking: 40 
years observations on male British doctors. BMJ. 
1994; 309: 901–911. DOI: https://doi.org/10.1136/
bmj.309.6959.901
Perez-Warnisher et al: Tobacco Use WorldwideArt. 9, page 8 of 9 
 45. Doll­ R,  Peto­ R,  Boreham­ J­ and Sutherland I. 
 Mortality in relation to smoking: 40 years obser-
vations on male British doctors. BMJ.  2004; 
328(7455): 1519. DOI: https://doi.org/10.1136/
bmj.38142.554479.AE
 46. Agaku IT, King BA, Husten CG, et al. Center 
for  Disease Control and Prevention (CDC). 
Tobacco  product use among adults-United States, 
2012–2013. MMWR Morbidity Mortality Weekly Rep. 
2014; 63: 542–7.
 47. Stanley KE. Lung cancer and tobacco – A global 
problem. Cancer Detect Prev. 1986; 9(1–2): 83–9.
 48. Egleston BL, Meireles SI, Flieder DB and 
 Clapper ML. Population-based trends in lung 
cancer incidence in women. Semin Oncol. 2009; 
36(6): 506–515. DOI: https://doi.org/10.1053/j.
seminoncol.2009.09.003
 49. Patel JD. Lung cancer in women. J Clin Oncol. 2005; 
23(14): 3212–8. DOI: https://doi.org/10.1200/
JCO.2005.11.486
 50. U.S. Department of Health and Human 
 Services. Women and Smoking: A Report of the 
Surgeon General; 2001.
 51. CDC. Mortality trends for selected smoking-
related diseases and breast cancer United States, 
1950–1990. Morbidity and Mortality Weekly Report. 
1993; 42(44): 857, 863–6.
 52. Freedman ND, Silverman DT, Hollenbeck AR, 
Schatzkin A and Abnet CC. Association between 
smoking and risk of bladder cancer among men and 
women. JAMA. 2011; 306(7): 737–45.
 53. Fletcher C, Peto R, Tinker C and Speizer FE. The 
natural history of chronic bronchitis and emphy-
sema. An eight-year study of early chronic obstructive 
lung disease in working men in London; 1976. 
 54. Scanlon D, Paul E, Connett J, Waller L, Altose 
D, et al. Smoking Cessation and Lung Function in 
Mild-to-Moderate Chronic Obstructive Pulmonary 
Disease. AJRCCM. 2000; 161(2).
 55. American Lung Association. Trends in COPD 
(Chronic Bronchitis and Emphysema): Morbid-
ity and Mortality Epidemiology and Statistics Unit 
Research and Health Education Division; 2013. 
 56. Mathers CD and Loncar D. Projections of Global 
Mortality and Burden of Disease from 2002 to 2030. 
Medicine. 2006; 209–224. 
 57. U.S. Department of Health and Human 
 Services. The Health Consequences of Smoking: A 
Report of the Surgeon General; 2004. 
 58. Jha P, Chaloupka F, Moore J, et al. Disease Con-
trol Priorities in Developing Countries. In: Tobacco 
Addiction. 2nd edition.
 59. U.S. Department of Health and Human 
Services. The Health Consequences of Smoking—50 
Years of Progress: A Report of the Surgeon General; 
2014.
 60. U.S. Department of Health and Human Services. 
The Health Consequences of Smoking—50 Years of 
Progress: A Report of the Surgeon General; 2014.
 61. Benowitz NL. Cigarette smoking and cardiovascular 
disease: pathophysiology and implications for treat-
ment. Prog Cardiovasc Dis. 2003; 46(1): 91–111. DOI: 
https://doi.org/10.1016/S0033-0620(03)00087-2
 62. Department of Health and Human Services. A 
Report of the Surgeon General: How Tobacco Smoke 
Causes Disease: What It Means to You; 2010.
 63. Rea TD, Heckbert SR, Kaplan RC, et al. 
 Smoking status and risk for recurrent coronary 
events after myocardial infarction. Ann Intern 
Med. 2002; 137(6): 494–500. DOI: https://doi.
org/10.7326/0003-4819-137-6-200209170-00009
 64. Huxley RR and Woodward M. Cigarette  smoking 
as a risk factor for coronary heart disease in women 
compared with men: A systematic review and 
meta-analysis of prospective cohort studies.  Lancet. 
2011; 378(9799): 1297–305. DOI: https://doi.
org/10.1016/S0140-6736(11)60781-2
 65. WHO. A WHO/The Union monograph on TB and 
tobacco control: Joining efforts to control two 
related global epidemics; 2007.
 66. Organización mundial de la Salud, Ginebra, 
Suiza. Convenio Marco para el control del tabaco. 
 67. Organización mundial de la Salud. Comercio 
 ílicito de productos del tabaco. Organización mun-
dial de la Salud.
 68. Haw SJ and Gruer L. Changes in exposure of 
adult non-smokers to secondhand smoke after 
implementation of smoke-free legislation in Scot-
land: National cross-sectional survey. BMJ. 2007; 
335(7619): 549. DOI: https://doi.org/10.1136/
bmj.39315.670208.47
 69. Kingsbury JH and Reckinger D. Clearing the air: 
Smoke-free housing policies, smoking, and second-
hand smoke exposure among affordable housing 
residents in Minnesota, 2014–2015. Prev Chronic 
Dis. 2016; 13: E111. DOI: https://doi.org/10.5888/
pcd13.160195
 70. Jones MR, Barnoya J, Stranges S, Losonczy L 
and Navas-Acien A. Cardiovascular events follow-
ing smoke-free legislations: An updated systematic 
review and meta-analysis. Curr Environ Health Rep. 
2014; 1(3): 239–249. DOI: https://doi.org/10.1007/
s40572-014-0020-1
 71. Tan CE and Glantz SA. Association between 
smoke-free legislation and hospitalizations 
for cardiac, cerebrovascular, and respiratory 
diseases: A meta-analysis. Circulation. 2012; 
126(18): 2177–83. DOI: https://doi.org/10.1161/
CIRCULATIONAHA.112.121301
 72. Fernández E, Fu M, Pascual JA, et al. Impact of 
the Spanish smoking law on exposure to second-
hand smoke and respiratory health in hospital-
ity workers: A cohort study. PLoS One. 2009; 4(1): 
e4244. DOI: https://doi.org/10.1371/journal.
pone.0004244
 73. Muggli ME, Lockhart NJ, Ebbert JO, 
 Jiménez-Ruiz CA, Riesco Miranda JA and Hurt 
RD. Legislating tolerance: Spain’s national public 
Perez-Warnisher et al: Tobacco Use Worldwide Art. 9, page 9 of 9 
smoking law. Tob Control. 2010; 19(1): 24–30. 
DOI: https://doi.org/10.1136/tc.2009.031831
 74. Jiménez Ruiz CA, Riesco Miranda JA, Altet 
Gómez N, et al. Impact of legislation on passive 
smoking in Spain. Respiration. 2014; 87(3): 190–5. 
DOI: https://doi.org/10.1159/000355083
 75. Pérez-Ríos­M,­Schiaffino­A,­López­MJ,­et al. Ques-
tionnaire-based second-hand smoke assessment in 
adults. Eur J Public Health. 2013; 23(5): 763–7. DOI: 
https://doi.org/10.1093/eurpub/cks069
 76. Martínez-Sánchez JM, Gallus S, Zuccaro P, 
Colombo P, Fernández E, Manzari M and La 
Vecchia C. Exposure to secondhand smoke in Ital-
ian non-smokers 5 years after the Italian smoking 
ban. Eur J Public Health. 2012; 22(5): 707–12. DOI: 
https://doi.org/10.1093/eurpub/ckr156
 77. Fang SC, Chen S, Trachtenberg F, Rokicki S, 
 Adamkiewicz G and Levy DE. Validity of self-
reported tobacco smoke exposure among non-smok-
ing adult public housing residents. PLoS One. 2016; 
11(5): e0155024. DOI: https://doi.org/10.1371/
journal.pone.0155024
 78. Blanke DD and Cork K. Exploring the limits of 
smoking regulation. William Mitchell Law Review. 
2008; 34(4): Article 12.
 79. Pederson A, Okoli CT, Hemsing N, et al. Smok-
ing on the margins: A comprehensive analysis 
of a municipal outdoor smoke-free policy. BMC 
Public Health. 2016; 16: 852. DOI: https://doi.
org/10.1186/s12889-016-3466-2
 80. Orton S, Jones LL, Cooper S, Lewis S and 
 Coleman T. Predictors of children’s secondhand 
smoke exposure at home: A systematic review and 
narrative synthesis of the evidence. PLoS One. 2014; 
9(11): e112690. DOI: https://doi.org/10.1371/jour-
nal.pone.0112690
 81. Thomas BP and Gostin LO. Tobacco endgame 
strategies: Challenges in ethics and law. Tob Control. 
2013; 22: i55–i57. DOI: https://doi.org/10.1136/
tobaccocontrol-2012-050839
How to cite this article: Perez-Warnisher MT, de Miguel MDPC and Seijo LM. Tobacco Use Worldwide: Legislative Efforts to Curb 
Consumption. Annals of Global Health. 2019; 85(1): 9, 1–9. DOI: https://doi.org/10.5334/aogh.2417
Published: 22 January 2019
Copyright: © 2019 The Author(s). This is an open-access article distributed under the terms of the Creative Commons 
Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.
Annals of Global Health is a peer-reviewed open access journal published by Ubiquity Press. OPEN ACCESS 
